PLUS THERAPEUTICS, INC.
Develops targeted radiotherapeutics for difficult-to-treat cancers in adults and children.
PSTV | US
Overview
Corporate Details
- ISIN(s):
- US23283K2042 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 4200 MARATHON BLVD., 78756 AUSTIN
- Website:
- http://www.plustherapeutics.com/
- Sector:
- Manufacturing
Description
Plus Therapeutics is a clinical-stage pharmaceutical company focused on developing targeted radiotherapeutics for difficult-to-treat cancers in adults and children. The company's technology platform is designed to deliver high-dose, localized radiation directly to tumors. Its core approach involves encapsulating Rhenium radioisotopes (186Re and 188Re) within nanoliposomes. The lead investigational drug, REYOBIQ™ (rhenium Re186 obisbemeda), is a nanoliposome therapy targeting brain and central nervous system (CNS) cancers, including recurrent glioblastoma and leptomeningeal metastases. A second pipeline program, Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere (188RNL-BAM), is a radioembolization therapy being developed for solid organ cancers, such as liver cancer. The use of Rhenium allows for both therapeutic beta radiation and gamma imaging during treatment.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2016-06-06 09:05 |
PROSPECTUS FILED PURSUANT TO RULE 424(B)(3)
|
English | 28.9 KB | ||
| 2016-06-06 09:02 |
CURRENT REPORT FILING
|
English | 17.5 KB | ||
| 2016-05-31 18:15 |
SPECIALIZED DISCLOSURE REPORT
|
English | 46.9 KB | ||
| 2016-05-31 09:10 |
PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(B)(3)
|
English | 29.2 KB | ||
| 2016-05-31 09:05 |
CURRENT REPORT FILING
|
English | 17.2 KB | ||
| 2016-05-27 02:15 | English | 5.1 KB | |||
| 2016-05-26 21:01 |
CYTORI THERAPEUTICS, INC 424B4 5-26-2016
|
English | 247.0 KB | ||
| 2016-05-25 09:10 | English | 7.9 KB | |||
| 2016-05-25 09:03 | English | 19.2 KB | |||
| 2016-05-25 09:00 |
CYTORI THERAPEUTICS, INC. S-1/A NO. 2 5-25-2016
|
English | 296.3 KB | ||
| 2016-05-24 18:30 | English | 106.2 KB | |||
| 2016-05-16 18:31 |
FORM 4
|
English | 6.4 KB | ||
| 2016-05-11 23:55 |
CYTORI THERAPEUTICS FWP 5-11-2016
|
English | 7.1 MB | ||
| 2016-05-10 22:17 | English | 10.9 KB | |||
| 2016-05-10 22:14 |
CYTORI THERAPEUTICS FORM S1
|
English | 375.4 KB |
Automate Your Workflow. Get a real-time feed of all PLUS THERAPEUTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PLUS THERAPEUTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PLUS THERAPEUTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
